Clinical tests begin on medication to correct Fragile X defect
                   
brightsurf.com
Nov 3, 2009 15 related
 

NIH-supported scientists at Seaside Therapeutics in Cambridge, Mass., are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile X syndrome, the most common... [read full story]                    

powered by
Add Comment
There are also 15 related articles
View all news articles about*:
Ambulatory America Assistance Behavior Birth Cambridge Care Child Defects Development Discoveries Disorders Genetics Health Humanitarian Learning Massachusetts Medical Mental North Pharmaceuticals Research Scientific Scientists States United
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

                   

Med BioGene Reports Financial Results for the Third Quarter of 2009

newsblaze.com
29 mins ago 1 related
 

VANCOUVER, BRITISH COLUMBIA - NOT FOR DISSEMINATION IN THE UNITED STATES OR TO UNITED STATES PERSONS OR FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES Med BioGene Inc. (TSX VENTURE:MBI) today reported its financial results...

add comment

powered by

CIBC presents Entrepreneurship 101 2008/09 - Collaboration in the Meltdown

viddler.com
11 mins ago 6 related
 

Speakers:John Abele, co founder and director of Boston Scientific Corporation Summary: In technology industries, breakthroughs increasingly demand the integration of multiple technical fields. Knowing how to achieve real...

add comment

powered by
                   

Mobile phone a big threat to children

bigblog.com
18 mins ago
 

The television set you frequently discourage your children from watching may not be their greatest threat. The mobile phone has become unrivalled in introducing children to cyberspace, posing a risk to their safety, a lobby...

add comment

powered by
                   

Tata offers roaming at just 1 paisa per sec

bigblog.com
18 mins ago
 

NEW DELHI: Intensifying the tariff war in mobile telephony, Tata DoCoMo, the GSM arm of Tata Teleservices, on Sunday extended its one-paisa-per-second billing scheme to roaming calls, regardless of the network or type of phone.

add comment

powered by